About Stabicon Life Sciences
Stabicon Life Sciences is a company based in Bengaluru (India) founded in 2010 by Suresh Khanna. It operates as a B2B. The company has 75 employees. Stabicon Life Sciences offers products and services including Stability Study, Formulation Research, Analytical Research, Microbial Analysis, and Technology Transfer. Stabicon Life Sciences operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Bengaluru, India
- Employees 75
- Founders Suresh Khanna
- SectorsHealthcareConsumer
- Email••••••••
- Phone•••• ••••
- Website stabicon.com
- Social LinkedIn X Facebook YouTube
- Legal Name Stabicon Life Sciences Private Limited
- Date of Incorporation 09 Feb, 2010
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹11.34 Cr
FY 2025 · +20% YoY
- Net Profit₹29.1 Lakh
FY 2025 · 3% margin
- EBITDA₹2.66 Cr
FY 2025 · 23% margin
- Employee Count75
Associated legal entities of Stabicon Life Sciences
Stabicon Life Sciences operates through Stabicon Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stabicon Life Sciences Private Limited CIN U73100KA2010PTC052428 | Active | 09 Feb 2010 | Bengaluru, Karnataka | ₹11.3 Cr | 75 | 2 | View details |
Products & Services of Stabicon Life Sciences
Stabicon Life Sciences offers a comprehensive portfolio of products and services, including Stability Study, Formulation Research, Analytical Research, Microbial Analysis, and Technology Transfer.
Conducts stability testing for product development phases.
Develops formulations for pharmaceuticals and nutraceuticals.
Performs method development and validation for products.
Tests for microbial limits and validation.
Supports technology transfer for product manufacturing.
Apps and channels of Stabicon Life Sciences
its YouTube channel Stabicon Life Sciences Pvt Ltd has 42 subscribers and 13 videos.
Videos from Stabicon Life Sciences
The most watched videos on Stabicon Life Sciences's YouTube channel, Stabicon Life Sciences Pvt Ltd (42 subscribers). Click a video to play it here.
More on Stabicon Life Sciences Pvt Ltd.
Board of directors of Stabicon Life Sciences Private Limited (Stabicon Life Sciences)
Stabicon Life Sciences Private Limited is the primary company behind Stabicon Life Sciences. The board of Stabicon Life Sciences Private Limited currently have 2 directors; the longest-serving is Kushboo Ranka, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kushboo Ranka DIN 02940157 | Director | 12 Feb 2010 | 16 yrs 7 mo | Stabicon Life Sciences Private Limited |
| Palaniandy Krishnamurthy DIN 08563432 | Director | 04 May 2021 | 5 yrs 5 mo | Stabicon Life Sciences Private Limited |
People of Stabicon Life Sciences
1 people are tracked at Stabicon Life Sciences (1 in leadership); the tracked headcount is 75.
| Name | Role | Group |
|---|---|---|
| Founder, Chairman | Leadership |
Complete people profiles for Stabicon Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Stabicon Life Sciences
Figures of Stabicon Life Sciences Private Limited, the primary company behind Stabicon Life Sciences, for FY 2025. Revenue was ₹11.34 Cr (+20% year on year). Net profit was ₹29.1 Lakh (3% margin). EBITDA was ₹2.66 Cr (23% margin). Revenue has grown at a compounded annual rate of +3% over three years and 0% over five years.
- ₹11.34 CrRevenue · FY 2025 · +20% YoY
- ₹29.1 LakhNet profit · 3% margin
- ₹2.66 CrEBITDA · 23% margin
- ₹3.70 CrPaid-up capital
- 75Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Stabicon Life Sciences Private Limited are on its company page.
Detailed financial statements for Stabicon Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Stabicon Life Sciences
Stabicon Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Stabicon Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Stabicon Life Sciences
10 companies that operate in the same segment as Stabicon Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stabicon Life Sciences
Stabicon Life Sciences was founded in 2010.
Stabicon Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Stabicon Life Sciences has 75 employees.
The primary company behind Stabicon Life Sciences, Stabicon Life Sciences Private Limited, reported revenue of ₹11.34 Cr for FY 2025, up 20% year on year.
Stabicon, established in 2010 in Bangalore, India, specializes in pharmaceutical and FMCG product development. It provides services such as stability testing, formulation research, analytical development, microbial analysis, and technology transfer to global clients including major pharmaceutical and FMCG companies. The company uses advanced technologies and expert teams to ensure quality and compliance with international standards, focusing on areas like OTC and nutraceuticals.
Stabicon Life Sciences's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Stabicon Life Sciences offers Stability Study, Formulation Research, Analytical Research, Microbial Analysis, and Technology Transfer.
Stabicon Life Sciences operates through Stabicon Life Sciences Private Limited.
The legal entities of Stabicon Life Sciences currently have 2 directors, including Palaniandy Krishnamurthy, Kushboo Ranka.